PSA Rising Our email address is on the anti-spam image!
JournalWatch :: Med Dictionary :: Clinical Trials :: PubMed

Nutri Briefs Archive

Cocoa has more than tea and wine Dec 21 2003

Update: Aug 2003
Resveratrol: a candidate nutritional substance for prostate cancer prevention.

Farmed Salmon PCBs

Magic Bullets or Whole Foods?
Fats and Oils
Super Broccoli
Soy Against Prostate Cancer
Fish Oil


The Prostate Diet Cookbook

by Buffy Sanders, Michael K. Brawer
$16.76 July 2001, Harbor Press


The ABC's of Nutrition & Supplements for Prostate Cancer by Mark A. Moyad

cover Stopping Cancer Before It Starts $16.95

PCa Links & Resources Content

Grape Compound Aids Cancer Chemotherapy, Study Says

grapes on the vine by hendoJune 30, 2000. A compound found in grapes and grape products such as red wine shows natural cancer-fighting properties that might be important in preventing or treating the illness, according to scientists at University of North Carolina at Chapel Hill.

The work appears to explain the so-called "French paradox" -- the fact that French people experience lower rates of heart disease death and certain cancers despite drinking more wine on average than U.S. residents do.

Scientists found that trans-Resveratrol, or Res, apparently helps turn off a protein in the body that prevents cancer cells from being killed, as they should. The protein, called NF-kappa B, attaches to DNA inside cell nuclei and turns genes on and off like a switch.

A report on the work appears in the July issue of Cancer Research, a scientific journal. Authors are Dr. Minnie Holmes-McNary, a nutritional biologist and postdoctoral fellow at the UNC-CH School of Medicine's Lineberger Comprehensive Cancer Center, and her mentor Dr. Albert S. Baldwin Jr., a biology professor who also works at the center.

"A couple of years ago, a group at the University of Illinois found that Res has both anti-inflammatory and anti-cancer properties,"Holmes-McNary said. "The question then became how does it exert its effects, and that's what we show in our paper."

Working with cultured human and rat cells, the scientists found that Res was a powerful inhibitor of the protein and appeared to work by controlling activity of another closely related protein called I-kappa B, which regulates NF-kappa activation.

"Using Res, we were able to promote apoptosis, a process that the body uses to kill cancer cells and other cells it needs to get rid of," Holmes-McNary said. "When Res was absent from the cell culture system, cancer cells continued to survive, but when Res was there under experimental conditions, we could successfully promote death of cancer cells by turning off NF-Kappa B."

Studies are now being planned to reproduce the findings in rodents, she said. If the animal experiments go well, the scientists may extend their work to humans within a few years. Epidemiological studies suggesting a protective effect of grapes and grape products such as red wine against heart disease and cancer began in the 1970s.

"This is very exciting work because we believe it explains how diet modulates changes at the molecular level," Homes-McNary said. "It provides a molecular rationale for the broad chemo-preventive properties of trans-Resveratrol and by extention, grapes and grape products."

Because the scientists also were able to inhibit a NF-kappa B dependent gene called MCP-1 that is involved in inflammation and development of atherosclerosis, the research also applies to cardiovascular disease, she added.

Res is found in many fruits and nuts, but is especially abundant in red grapes, mulberries, raspberries and peanuts, the scientist said. For that reason, she recommends that people consume more of them. Muscadine grapes, including scuppernongs, are rich sources of the compound.

Muscadine wines contain up to seven times more resveratrol than regular wines

Three years ago, Baldwin and other UNC-CH researchers first reported that NF-kappa B enables many cultured tumor cells to escape death when subjected to cancer-killing chemicals. After developing resistance to chemotherapy, cancer cells they studied continued reproducing and showed no ill effects from the treatment.

Last year, the scientists used a novel cancer gene therapy strategy to block NF-kappa B in mice with I-kappa B. Human tumors growing in the mice then became susceptible to chemotherapy and in some cases disappeared altogether following treatment.

Previously, no one had understood why many tumors become unresponsive to chemotherapy and radiation after a while, Baldwin said. NF-kappa B appears to be a front-line defense protecting both healthy cells -- and unfortunately cancer cells as well -- from chemical attack and other trauma.

In experiments reported last year, Baldwin and Dr. James C. Cusack Jr. of UNC-CH concentrated on human colorectal and fibrosarcoma tumors. They grew the tumors in mice and then treated them with a modified form of the inhibitor I-kappa B carried by a virus that could enter tumor cells. Treatment with a commonly used chemotherapy compound known as CPT-11 was far more successful, Baldwin said, when coupled with I-kappa B than when used by itself.

"These potential therapies, combined with dietary interventions such as incorporation of Res into the diet, hold exciting possibilities for cancer treatment," Holmes-McNary said.

Support for the studies came from the National Cancer Institute and the N.C. affiliate of the American Heart Association.

Source: U of North Carolina. Story posted June 30, 2000. Page links last updated Dec 21 2003.


University of North Carolina at Chapel Hill

I-Kappa B, New Gene Switch, May Make Radiation and Chemotherapy More Effective (March 1999)

Homepage :: Cancer Newswire :: Site Guide Archive
EatingWell :: Voices for Survival :: Grassroots :: MedBriefs Archive
Books :: JournalWatch :: PCa Links & Resources :: WiredBird Drug Company PR
:: Letters :: Forum :: Content Policy :: Privacy :: About Us
:: Subscribe ::

PSA Rising
prostate cancer activist news
PO Box 2519, New York, NY, 10021